Phenolic compounds, including resveratrol (RES), kaempferol (KAE), and (-)-epigallocatechin gallate (EGCG), have been validated through cell-based assays [18], demonstrating their ability to modify the structure of apoE4 and mitigate its pathogenic role in Alzheimer’s disease (AD). This evidence concerns the gene APOE and Alzheimer disease.